Error: Could not add to watchlist. X

Tekla Life Sciences Investors

+ Watchlist
HQL:US
New York
26.31
USD
0.11
0.42%
As of 20:04:04 ET on 09/04/2015.
Open
26.18
Day Range
25.95 - 26.58
Previous Close
26.42
52Wk Range
19.24 - 31.21
1 Yr Return
28.68%
YTD Return
12.15%
Open
26.18
Day Range
25.95 - 26.58
Volume
44,936
Previous Close
26.42
52Wk Range
19.24 - 31.21
1 Yr Return
28.68%
YTD Return
12.15%
NAV (on 09/04/2015)
26.59
Total Assets (m USD) (on 06/26/2015)
562.317
Inception Date
05/08/1992
Premium/Discount
-1.05%
Average 52-Week Premium
-0.69%
Fund Managers
DANIEL R OMSTEAD "DAN"
Last Dividend (on 08/26/2015)
0.58
Dividend Indicated Gross Yield
8.82%
Expense Ratio
1.32%
3 Mo Return
-2.97%
3 Yr Return
31.78%
5 Yr Return
35.27%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 443.12 k 51.88 m 9.21
Celgene Corp 436.32 k 50.50 m 8.96
Biogen Inc 69.08 k 27.90 m 4.95
Regeneron Pharmaceuticals Inc 54.52 k 27.81 m 4.94
Incyte Corp 259.92 k 27.09 m 4.81
Mylan NV 390.32 k 26.49 m 4.70
Alexion Pharmaceuticals Inc 127.80 k 23.10 m 4.10
Vertex Pharmaceuticals Inc 180.23 k 22.25 m 3.95
BioMarin Pharmaceutical Inc 128.43 k 17.57 m 3.12
Teva Pharmaceutical Industries 287.32 k 16.98 m 3.01
Profile
Tekla Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies and primarily in securities of public and private companies that are believed to have significant potential for above-average growth.
ADDRESS
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
PHONE
1-617-772-8500